Toronto, Ontario--(Newsfile Corp. - September 20, 2021) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company") is pleased to announce the results of its special meeting of shareholders (the "Special Meeting" or "Meeting") held on Monday, September 20, 2021.
All matters presented for approval at the Meeting were duly authorized and approved as follows:
- the approval of the amendment to the articles of amendment of the Company, to change its name to such name as the directors of the Company, in their sole discretion, may determine and as may be acceptable to the Director appointed under the Business Corporations Act (Ontario).
The Company held a Special Meeting to approve a Name Change as the Company's core competencies and product offerings have organically grown beyond the medical device industry, and this expansion into new industries and businesses will be reflected in the Name Change. The Company's new name will more aptly and effectively communicate the business and its commercial verticals.
Further details on the above matter are available under the Company's profile on www.sedar.com.
RECENT NEWS: Relay recently announced an agreement with Unisys Corp. to market a combined solution for COVID-19 and biosecurity market needs: https://bit.ly/3AqDI0h
SUBSCRIBE: For more information on Relay or to subscribe to the Company's mail list visit: https://www.relaymedical.com/news
About Relay Medical Corp.
Relay Medical is a technology innovator headquartered in Toronto, Canada focused on the development of novel solutions in the diagnostics, AI data science and IoT security sectors. Relay recently acquired Cybeats Technologies, a platform which offers a holistic approach to cybersecurity and addresses the $73 billion IoT security market through their Software Bill of Materials and microagent solution. Cybeats provides real-time cybersecurity for connected devices, critical infrastructure, automotive, medical and IoT (Internet of Things) sectors.
Forward-looking Information Cautionary Statement
Except for statements of historic fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Company's control. There are no assurances that the commercialization plans for the technology described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company's filings with Canadian securities regulators, which filings are available at www.sedar.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/97028
News Provided by Newsfile Corp.